Skip to menu Skip to content Skip to footer
Dr Shehzahdi Moonshi
Dr

Shehzahdi Moonshi

Email: 

Overview

Background

Dr Shehzahdi (Sheb) Moonshi is a nanobiologist and translational immunology researcher at the University of Queensland’s Frazer Institute and Translational Research Institute (TRI). Her research focuses on developing antigen-specific immunotherapies (ASI) and nanoparticle-based precision medicines to treat autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.

At TRI (2025), she has translated this skillset to optimise antigen-specific liposomal nanotherapies for in vitro stability and evaluate their biodistribution and efficacy in vivo using preclinical models of autoimmune disease. She has also developed unique expertise in creating scalable, immune-targeted delivery platforms for clinical translation through close collaboration with a Clinical Drug Manufacturing Organisation for the scale-up and manufacture of ASITI-RA, a rheumatoid arthritis antigen-specific immunotherapy.

Her broader expertise spans:

  • Nanomedicine formulation and characterisation

  • Translational immunology and preclinical model development (humanised mice)

  • Collaborative, consumer-partnered, and clinician-led translational research

Dr Moonshi’s goal is to advance precision immunotherapies that restore immune tolerance and transform outcomes for people with autoimmune and inflammatory diseases.

Availability

Dr Shehzahdi Moonshi is:
Available for supervision

Research interests

  • Liposomal Nanomedicine for Autoimmune Therapy

    I develop and optimise liposomal nanotherapies that co-encapsulate disease-specific peptides and immune modulators for targeted lymph-node delivery. My work focuses on formulation stability, biodistribution, and clinical-scale manufacture of precision nanomedicines for autoimmune disease.

  • Translational Immunology and Preclinical Models

    I use humanised and SKG mouse models to study immune regulation, macrophage modulation, and therapeutic tolerance induction. These models enable preclinical testing and translation of antigen-specific immunotherapies toward clinical application.

Research impacts

Dr Shehzahdi (Sheb) Moonshi’s research bridges nanomedicine and immunology to create next-generation, antigen-specific immunotherapies (ASI) that retrain—rather than suppress—the immune system in autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.

Collaborating with clinical and industry partners, she has helped advance this technology from lab-scale formulation to GMP-compatible manufacture, demonstrating real-world feasibility for clinical use.

At TRI, Dr Moonshi leads the optimisation of immune-targeted liposomal platforms that enhance drug stability, precision, and safety. These innovations are now being extended to other autoimmune conditions, creating a scalable platform for personalised tolerance-inducing therapies.

Her research impact extends beyond the laboratory through:

  • Partnerships with clinicians and biotechnology companies to accelerate clinical translation.

  • Active consumer engagement to align therapeutic design with patient priorities.

  • Mentorship and collaboration that build Australia’s capacity in nanomedicine and translational immunology.

Together, these efforts are helping redefine how autoimmune diseases are treated—paving the way for safer, more durable, and targeted immune tolerance therapies.

Works

Search Professor Shehzahdi Moonshi’s works on UQ eSpace

46 works between 2012 and 2025

21 - 40 of 46 works

2023

Conference Publication

Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy

Moonshi, Shehzahdi S., Vazquez-Prada, K. X., Tang, J. and Ta, Hang Thu (2023). Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy. Griffith University Cancer Symposium, Brisbane, QLD Australia, 2 Dec 2023.

Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy

2023

Journal Article

Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy

Moonshi, Shehzahdi S., Vazquez-Prada, Karla X., Tang, Joyce, Westra van Holthe, Nicholas J., Cowin, Gary, Wu, Yuao, Tran, Huong D. N., Mckinnon, Ryan, Bulmer, Andrew C. and Ta, Hang Thu (2023). Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy. ACS Applied Materials and Interfaces, 15 (36), 42153-42169. doi: 10.1021/acsami.3c04696

Spiky silver–iron oxide nanohybrid for effective dual-imaging and synergistic thermo-chemotherapy

2023

Journal Article

Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis

Fithri, Najma Annuria, Wu, Yuao, Cowin, Gary, Akhter, Fahima, Tran, Huong D.N., Tse, Brian, van Holthe, Nicholas Westra, Moonshi, Shehzahdi S., Peter, Karlheinz, Wang, Xiaowei, Truong, Nghia P. and Ta, Hang Thu (2023). Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis. Applied Materials Today, 31 101750, 1-14. doi: 10.1016/j.apmt.2023.101750

Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis

2023

Journal Article

Frontispiece - A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis (Small 11/2023)

Vazquez‐Prada, Karla X., Moonshi, Shehzahdi S., Wu, Yuao, Akther, Fahima, Tse, Brian W.C., Sokolowski, Kamil A., Peter, Karlheinz, Wang, Xiaowei, Xu, Zhi Ping (Gordon) and Ta, Hang Thu (2023). Frontispiece - A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis (Small 11/2023). Small, 19 (11) 2370070. doi: 10.1002/smll.202370070

Frontispiece - A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis (Small 11/2023)

2023

Journal Article

Nanoceria: an innovative strategy for cancer treatment

Tang, Joyce L. Y., Moonshi, Shehzahdi S. and Ta, Hang T. (2023). Nanoceria: an innovative strategy for cancer treatment. Cellular and Molecular Life Sciences, 80 (2) 46, 1-34. doi: 10.1007/s00018-023-04694-y

Nanoceria: an innovative strategy for cancer treatment

2023

Journal Article

A spiky silver‐iron oxide nanoparticle for highly efficient targeted photothermal therapy and multimodal imaging of thrombosis

Vazquez‐Prada, Karla X., Moonshi, Shehzahdi S., Wu, Yuao, Akther, Fahima, Tse, Brian W.C., Sokolowski, Kamil A., Peter, Karlheinz, Wang, Xiaowei, Xu, Gordon and Ta, Hang Thu (2023). A spiky silver‐iron oxide nanoparticle for highly efficient targeted photothermal therapy and multimodal imaging of thrombosis. Small, 19 (11) 2205744, 1-15. doi: 10.1002/smll.202205744

A spiky silver‐iron oxide nanoparticle for highly efficient targeted photothermal therapy and multimodal imaging of thrombosis

2022

Journal Article

Placenta‐derived mesenchymal stem cells for treatment of diseases: a clinically relevant source

Moonshi, Shehzahdi S., Adelnia, Hossein, Wu, Yuao and Ta, Hang T. (2022). Placenta‐derived mesenchymal stem cells for treatment of diseases: a clinically relevant source. Advanced Therapeutics, 5 (10) 2200054, 1-14. doi: 10.1002/adtp.202200054

Placenta‐derived mesenchymal stem cells for treatment of diseases: a clinically relevant source

2022

Journal Article

Visualizing stem cells in vivo using magnetic resonance imaging

Moonshi, Shehzahdi Shebbrin, Wu, Yuao and Ta, Hang Thu (2022). Visualizing stem cells in vivo using magnetic resonance imaging. WIREs Nanomedicine and Nanobiotechnology, 14 (2) e1760, 1-20. doi: 10.1002/wnan.1760

Visualizing stem cells in vivo using magnetic resonance imaging

2022

Journal Article

Freeze/thawed polyvinyl alcohol hydrogels: present, past and future

Adelnia, Hossein, Ensandoost, Reza, Shebbrin Moonshi, Shehzahdi, Gavgani, Jaber Nasrollah, Vasafi, Emad Izadi and Ta, Hang Thu (2022). Freeze/thawed polyvinyl alcohol hydrogels: present, past and future. European Polymer Journal, 164 110974, 110974. doi: 10.1016/j.eurpolymj.2021.110974

Freeze/thawed polyvinyl alcohol hydrogels: present, past and future

2021

Journal Article

Engineering chitosan nano-cocktail containing iron oxide and ceria: a two-in-one approach for treatment of inflammatory diseases and tracking of material delivery

Wu, Yuao, Cowin, Gary, Moonshi, Shehzahdi S., Tran, Huong D. N., Fithri, Najma Annuria, Whittaker, Andrew K., Zhang, Run and Ta, Hang T. (2021). Engineering chitosan nano-cocktail containing iron oxide and ceria: a two-in-one approach for treatment of inflammatory diseases and tracking of material delivery. Materials Science and Engineering C, 131 112477, 1-15. doi: 10.1016/j.msec.2021.112477

Engineering chitosan nano-cocktail containing iron oxide and ceria: a two-in-one approach for treatment of inflammatory diseases and tracking of material delivery

2021

Journal Article

Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage

Tran, Huong D. N., Moonshi, Shehzahdi Shebbrin, Xu, Zhi Ping and Ta, Hang Thu (2021). Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage. Biomaterials Science, 10 (1), 10-50. doi: 10.1039/d1bm01351c

Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage

2021

Journal Article

Silver/iron oxide nano-popcorns for imaging and therapy

Rehman, Ateeque ur, Wu, Yuao, Tran, Huong D. N., Vazquez-Prada, Karla, Liu, Yajun, Adelnia, Hossein, Kurniawan, Nyoman D., Anjum, Muhammad Naeem, Moonshi, Shehzahdi S. and Ta, Hang T. (2021). Silver/iron oxide nano-popcorns for imaging and therapy. ACS Applied Nano Materials, 4 (10) acsanm.1c01571, 10136-10147. doi: 10.1021/acsanm.1c01571

Silver/iron oxide nano-popcorns for imaging and therapy

2021

Journal Article

Chitosan nanococktails containing both ceria and superparamagnetic iron oxide nanoparticles for reactive oxygen species-related theranostics

Wu, Yuao, Zhang, Run, Tran, Huong D. N., Kurniawan, Nyoman D., Moonshi, Shehzahdi S., Whittaker, Andrew K. and Ta, Hang T. (2021). Chitosan nanococktails containing both ceria and superparamagnetic iron oxide nanoparticles for reactive oxygen species-related theranostics. ACS Applied Nano Materials, 4 (4) acsanm.1c00141, 3604-3618. doi: 10.1021/acsanm.1c00141

Chitosan nanococktails containing both ceria and superparamagnetic iron oxide nanoparticles for reactive oxygen species-related theranostics

2020

Journal Article

Correction to High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging

Zhang, Cheng, Moonshi, Shehzahdi Shebbrin, Wang, Wenqian, Ta, Hang Thu, Han, Yanxiao, Han, Felicity Y., Peng, Hui, Král, Petr, Rolfe, Barbara E., Gooding, J. Justin, Gaus, Katharina and Whittaker, Andrew K. (2020). Correction to High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging. ACS Nano, 14 (10), 14245-14246. doi: 10.1021/acsnano.0c07373

Correction to High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging

2018

Other Outputs

Innovative Approaches to Tracking of Mesenchymal Stem Cells: In Vivo Tracking of Mesenchymal Stem Cells Using 19F MRI

Moonshi, Shehzahdi (2018). Innovative Approaches to Tracking of Mesenchymal Stem Cells: In Vivo Tracking of Mesenchymal Stem Cells Using 19F MRI. PhD Thesis, Australian Institute for Bioengineering & Nanotechnology, The University of Queensland. doi: 10.14264/uql.2018.831

Innovative Approaches to Tracking of Mesenchymal Stem Cells: In Vivo Tracking of Mesenchymal Stem Cells Using 19F MRI

2018

Journal Article

High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging

Zhang, Cheng, Moonshi, Shehzahdi Shebbrin, Wang, Wenqian, Ta, Hang Thu, Han, Yanxiao, Han, Felicity Y., Peng, Hui, Král, Petr, Rolfe, Barbara E., Gooding, John Justin, Gaus, Katharina and Whittaker, Andrew Keith (2018). High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging. ACS Nano, 12 (9) acsnano.8b03726, 9162-9176. doi: 10.1021/acsnano.8b03726

High F-content perfluoropolyether-based nanoparticles for targeted detection of breast cancer by 19F magnetic resonance and optical imaging

2018

Journal Article

A unique 19F MRI agent for the tracking of non phagocytic cells in vivo

Moonshi, Shehzahdi S., Zhang, Cheng, Peng, Hui, Puttick, Simon, Rose, Stephen, Fisk, Nicholas M., Bhakoo, Kishore, Stringer, Brett W., Qiao, Greg G., Gurr, Paul A. and Whittaker, Andrew K. (2018). A unique 19F MRI agent for the tracking of non phagocytic cells in vivo. Nanoscale, 10 (17), 8226-8239. doi: 10.1039/c8nr00703a

A unique 19F MRI agent for the tracking of non phagocytic cells in vivo

2018

Conference Publication

High F-Content Perfluoropolyether-based Polymers for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging

Zhang, Cheng, Moonshi, Shehzahdi Shebbrin, Ta, Hang T., Han, Yanxiao, Han, Felicity Y., Peng, Hui, Král, Petr, Rolfe, Barbara E. and Whittaker, Andrew K. (2018). High F-Content Perfluoropolyether-based Polymers for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging. World Polymer Congress Macro 2018, Cairns QLD Australia, 1-5 July 2018.

High F-Content Perfluoropolyether-based Polymers for Targeted Detection of Breast Cancer by 19F Magnetic Resonance and Optical Imaging

2017

Journal Article

PFPE-Based Polymeric 19F MRI Agents: A New Class of Contrast Agents with Outstanding Sensitivity

Zhang, Cheng, Moonshi, Shehzahdi Shebbrin, Han, Yanxiao, Puttick, Simon, Peng, Hui, Magoling, Bryan John Abel, Reid, James C., Bernardi, Stefano, Searles, Debra J., Král, Petr and Whittaker, Andrew K. (2017). PFPE-Based Polymeric 19F MRI Agents: A New Class of Contrast Agents with Outstanding Sensitivity. Macromolecules, 50 (15), 5953-5963. doi: 10.1021/acs.macromol.7b01285

PFPE-Based Polymeric 19F MRI Agents: A New Class of Contrast Agents with Outstanding Sensitivity

2016

Journal Article

Ion-responsive 19F MRI contrast agents for the detection of cancer cells

Zhang, Cheng, Moonshi, Shehzahdi Shebbrin, Peng, Hui, Puttick, Simon, Reid, James, Bernardi, Stefano, Bernhardt, Debra J. and Whittaker, Andrew K. (2016). Ion-responsive 19F MRI contrast agents for the detection of cancer cells. ACS Sensors, 1 (6), 757-765. doi: 10.1021/acssensors.6b00216

Ion-responsive 19F MRI contrast agents for the detection of cancer cells

Supervision

Availability

Dr Shehzahdi Moonshi is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Shehzahdi Moonshi's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au